ConductScience.org, home

Paper39385196

US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy.

Ren L and 13 others. J Nanobiotechnology, 2024. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy. Papers, record 39385196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39385196

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy.
PubMed
Journal
J Nanobiotechnology
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
2.36, provisional
iCite
Revised in PubMed
2024-10-12
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ren LLi
2Wang YYaotai
3Tang YYu
4Wang FFang
5Du YYan
6Ou XXia
7Lin LLi
8Zhang ZZhong
9Ding YYan
10Wu MMeixian
11Zhou YYijun
12Zhang MMingyang
13Wang QQi
14Zou JJianzhong

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Escherichia coliMajor topic
Multimodal ImagingMajor topic
Polylactic Acid-Polyglycolic Acid CopolymerMajor topic
Animals
Mice
Cell Line, Tumor
Magnetic Resonance Imaging
Neoplasms
Fluorocarbons
Polyethyleneimine
Humans
Genetic Engineering
Mice, Inbred BALB C
Photoacoustic Techniques
Female
Nanoparticles
Epirubicin
Polyglycolic Acid
Lactic Acid
High-Intensity Focused Ultrasound Ablation

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
I01 HX000132HSRD VAUnited StatesI01HX000132PubMed and NIHNIH RePORTER
CSTB2023NSCQ-BHX0132Chongqing Natural Science Foundation Post doctoral FundPubMedPubMed

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133010331Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation.J Control Release2021https://conductscience.org/library/papers/33010331PubMed
230659129Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer.J Natl Compr Canc Netw2019https://conductscience.org/library/papers/30659129PubMed
337362333Tumor-homing bacterium-adsorbed liposomes encapsulating perfluorohexane/doxorubicin enhance pulsed-focused ultrasound for tumor therapy.RSC Adv2023https://conductscience.org/library/papers/37362333PubMed
437926100
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol2023https://conductscience.org/library/papers/37926100PubMed
534818953Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems.Crit Rev Anal Chem2023https://conductscience.org/library/papers/34818953PubMed
638159557Factors associated with thermal injury of abdominal skin in focused ultrasound ablation of uterine fibroids.Int J Hyperthermia2024https://conductscience.org/library/papers/38159557PubMed
735931281Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy.Acta Biomater2022https://conductscience.org/library/papers/35931281PubMed
835814614US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy.Int J Nanomedicine2022https://conductscience.org/library/papers/35814614PubMed
929507623Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound.Theranostics2018https://conductscience.org/library/papers/29507623PubMed
1036937280Synergistic antibacterial effects of ultrasound combined nanoparticles encapsulated with cellulase and levofloxacin on Bacillus Calmette-Guérin biofilms.Front Microbiol2023https://conductscience.org/library/papers/36937280PubMed
1134374945High-Intensity Focused Ultrasound: A Review of Mechanisms and Clinical Applications.Ann Biomed Eng2021https://conductscience.org/library/papers/34374945PubMed
1238442747Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38442747PubMed
1333898560A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis.Hepatobiliary Surg Nutr2021https://conductscience.org/library/papers/33898560PubMed
1438598407Dynamic Mode Decomposition for Transient Cavitation Bubbles Imaging in Pulsed High-Intensity Focused Ultrasound Therapy.IEEE Trans Ultrason Ferroelectr Freq Control2024https://conductscience.org/library/papers/38598407PubMed
1531339599Comparative Study of Pulsed Versus Continuous High-Intensity Focused Ultrasound Ablation Using In Vitro and In Vivo Models.J Ultrasound Med2020https://conductscience.org/library/papers/31339599PubMed
1638409678Truly Tiny Acoustic Biomolecules for Ultrasound Imaging and Therapy.Adv Mater2024https://conductscience.org/library/papers/38409678PubMed
1735300712Ultrasound and nanomaterial: an efficient pair to fight cancer.J Nanobiotechnology2022https://conductscience.org/library/papers/35300712PubMed
1838099828High-Intensity Focused Ultrasound Surgery for Tumor Ablation: A Review of Current Applications.Radiol Imaging Cancer2024https://conductscience.org/library/papers/38099828PubMed
1934960243Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy.Vaccines (Basel)2021https://conductscience.org/library/papers/34960243PubMed
2033447030Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy.Int J Nanomedicine2021https://conductscience.org/library/papers/33447030PubMed

See all 60 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42694636Nanotechnology-Driven Ultrasound/Photoacoustic Theranostics for Real-Time Imaging and Therapeutics.Nanotheranostics2026https://conductscience.org/library/papers/42694636PubMed
42230745Development and validation of a clinical prediction model for the success of focused ultrasound ablation system for the treatment of adenomyosis.Sci Rep2026https://conductscience.org/library/papers/42230745PubMed
42068786Cavitation behaviors of genetically engineered bacterial protein nanoparticles induced by pulsed ultrasound.Ultrason Sonochem2026https://conductscience.org/library/papers/42068786PubMed
41764403Ultrasound-Responsive Engineered Bacteria for Targeted Cancer Therapy: Strategies, Mechanisms, and Applications.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41764403PubMed
41584827Advances in novel biomaterials for cardiovascular tissue engineering and regenerative medicine.PeerJ2026https://conductscience.org/library/papers/41584827PubMed
41470489Multifunctional Nanoplatforms Bridging Diagnostics and Therapeutics in Cancer.Micromachines (Basel)2025https://conductscience.org/library/papers/41470489PubMed
41050416Multifunctional PLGA nanosystems: enabling integrated diagnostic and therapeutic strategies.Front Pharmacol2025https://conductscience.org/library/papers/41050416PubMed
40887201[Advances in multimodal biomedical imaging of small animals].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi2025https://conductscience.org/library/papers/40887201PubMed
40585028Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy.Mater Today Bio2025https://conductscience.org/library/papers/40585028PubMed
40468414Genetically engineered bacteria-based nanocomposite synergistic HIFU for tumor therapy by changing the acoustic environment of tumor tissues.Cancer Cell Int2025https://conductscience.org/library/papers/40468414PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39385196

GET https://conductscience.org/api/papers/v1/39385196/references?page=2